Compounds, compositions, and methods are provided for treatment of disorders
related to mitochondrial dysfunction. The methods comprise administering to a mammal
a composition containing pyrimidine nucleotide precursors in amounts sufficient
to treat symptoms resulting from mitochondrial respiratory chain deficiencies.